Predicting MCI progression with FDG-PET and cognitive scores: a longitudinal study

BACKGROUND: Mild cognitive impairment (MCI) is an intermediate stage between normal aging and dementia. Studies on MCI progression are important for Alzheimer’s disease (AD) prevention. 18F fluoro-deoxy-glucose positron emission tomography (FDG-PET) has been proven to be a powerful tool for measurin...

Descripción completa

Detalles Bibliográficos
Autores principales: Teng, Lirong, Li, Yongchao, Zhao, Yu, Hu, Tao, Zhang, Zhe, Yao, Zhijun, Hu, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171825/
https://www.ncbi.nlm.nih.gov/pubmed/32316912
http://dx.doi.org/10.1186/s12883-020-01728-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171825/
https://www.ncbi.nlm.nih.gov/pubmed/32316912
http://dx.doi.org/10.1186/s12883-020-01728-x

Ejemplares similares